Cytosorbents Corporation Share Price
Stocks
CTSO
US23283X2062
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4500 USD | +4.90% |
|
-7.90% | -31.27% |
| 14/05 | Cytosorbents Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 14/05 | Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 2.69Cr 2.37Cr 2.19Cr 2.05Cr 3.83Cr 253.92Cr 3.91Cr 26Cr 10Cr 125.26Cr 10Cr 9.89Cr 435.8Cr | P/E 2026 * |
-2.32x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69Cr 2.37Cr 2.19Cr 2.05Cr 3.83Cr 253.92Cr 3.91Cr 26Cr 10Cr 125.26Cr 10Cr 9.89Cr 435.8Cr | EV / Sales 2026 * |
0.7x | EV / Sales 2027 * | 0.57x |
| Free-Float |
84.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytosorbents Corporation
| 1 day | +4.90% | ||
| 1 week | -7.90% | ||
| Current month | -10.51% | ||
| 1 month | -5.04% | ||
| 3 months | -36.86% | ||
| 6 months | -36.28% | ||
| Current year | -31.27% |
| 1 week | 0.41 |  | 0.5 |
| 1 month | 0.37 | | 0.6 |
| Current year | 0.37 | | 0.84 |
| 1 year | 0.37 | | 1.3 |
| 3 years | 0.37 | | 4.29 |
| 5 years | 0.37 | | 9.8 |
| 10 years | 0.37 | | 14.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 55 | 24/07/2008 |
Peter Mariani
DFI | Director of Finance/CFO | 62 | 14/08/2024 |
Vincent Capponi
PSD | President | 68 | 28/04/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Jones
BRD | Director/Board Member | 77 | 25/07/2011 |
Phillip Chan
BRD | Director/Board Member | 55 | 01/01/2009 |
Alan Sobel
BRD | Director/Board Member | 65 | 13/11/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06 | Buy | Chief Executive Officer | 10,333 | 0.0165% | ||
| 15/06 | Buy | Chief Financial Officer | 1,00,000 | 0.1592% | ||
| 18/11 | Free | Chief Executive Officer | 1,00,000 | 0.1593% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.90% | -7.90% | -63.39% | -87.23% | 2.69Cr | |
| +3.47% | +5.74% | +20.73% | -6.48% | 17TCr | |
| -0.74% | -0.09% | -23.18% | +23.57% | 14TCr | |
| +4.39% | +5.34% | -5.17% | -21.28% | 13TCr | |
| -2.27% | -0.34% | -56.98% | -16.27% | 6.78TCr | |
| +2.49% | +3.02% | +17.73% | -0.21% | 5.01TCr | |
| -0.84% | -1.21% | -27.01% | -32.27% | 4.38TCr | |
| +3.17% | +5.37% | +11.37% | +10.68% | 3.58TCr | |
| +2.84% | +3.25% | +6.29% | +41.91% | 3.51TCr | |
| +1.48% | +5.89% | -10.04% | -16.77% | 2.9TCr | |
| Average | +1.89% | -3.20% | -12.97% | -10.44% | 7.05TCr | |
| Weighted average by Cap. | +1.77% | -2.03% | -5.92% | -2.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.83Cr 3.37Cr 3.11Cr 2.91Cr 5.45Cr 360.67Cr 5.55Cr 37Cr 14Cr 177.91Cr 14Cr 14Cr 618.99Cr | 4.71Cr 4.15Cr 3.83Cr 3.58Cr 6.71Cr 444.17Cr 6.83Cr 46Cr 18Cr 219.11Cr 18Cr 17Cr 762.32Cr |
| Net income | -1.17Cr -1.03Cr -95.34L -89.17L -1.67Cr -110.67Cr -1.7Cr -11Cr -4.44Cr -55Cr -4.41Cr -4.31Cr -189.94Cr | 23.73L 20.89L 19.27L 18.02L 33.77L 22Cr 34.4L 2.32Cr 89.7L 11Cr 89.09L 87.16L 38Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $0.4393 | +2.40% | 69,731 |
| 23/26/23 | $0.4290 | +3.87% | 50,517 |
| 22/26/22 | $0.4130 | -5.77% | 47,407 |
| 18/26/18 | $0.4383 | -8.11% | 1,45,610 |
| 17/26/17 | $0.4770 | -8.07% | 1,94,654 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTSO Stock
Select your edition
All financial news and data tailored to specific country editions
